Kenneth M. Bahrt
2016 - Outlook Therapeutics
In 2016, Kenneth M. Bahrt earned a total compensation of $412.4K as Chief Medical Officer at Outlook Therapeutics.
Compensation breakdown
| Salary | $310,202 |
|---|---|
| Stock Awards | $80,040 |
| Other | $22,174 |
| Total | $412,416 |
Bahrt received $310.2K in salary, accounting for 75% of the total pay in 2016.
Bahrt also received $80K in stock awards and $22.2K in other compensation.
Rankings
In 2016, Kenneth M. Bahrt's compensation ranked 11,818th out of 14,075 executives tracked by ExecPay. In other words, Bahrt earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,818 out of 14,075 | 16th |
Division Manufacturing | 4,620 out of 5,486 | 16th |
Major group Chemicals And Allied Products | 1,652 out of 1,900 | 13th |
Industry group Drugs | 1,340 out of 1,543 | 13th |
Industry Biological Products, Except Diagnostic Substances | 244 out of 287 | 15th |
Source: SEC filing on August 17, 2018.
Bahrt's colleagues
We found three more compensation records of executives who worked with Kenneth M. Bahrt at Outlook Therapeutics in 2016.